91 related articles for article (PubMed ID: 16469690)
1. Rejuvenating exhausted T cells during chronic viral infection.
Okazaki T; Honjo T
Cell; 2006 Feb; 124(3):459-61. PubMed ID: 16469690
[TBL] [Abstract][Full Text] [Related]
2. Immunology: exhausted T cells perk up.
Williams MA; Bevan MJ
Nature; 2006 Feb; 439(7077):669-70. PubMed ID: 16467825
[No Abstract] [Full Text] [Related]
3. Restoring function in exhausted CD8 T cells during chronic viral infection.
Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
[TBL] [Abstract][Full Text] [Related]
4. Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade.
Freeman GJ; Wherry EJ; Ahmed R; Sharpe AH
J Exp Med; 2006 Oct; 203(10):2223-7. PubMed ID: 17000870
[TBL] [Abstract][Full Text] [Related]
5. Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade.
Yao S; Chen L
Trends Mol Med; 2006 Jun; 12(6):244-6. PubMed ID: 16650803
[TBL] [Abstract][Full Text] [Related]
6. [Up-expression of PD-1-PD-L induced by immunization with SEA and SMWA of Schistosoma japonicum in mice].
Wang L; Mo HM; Wang QH; Jiang ZW; Cheng YL; Liu WQ; Li YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Jun; 26(3):170-3. PubMed ID: 19160960
[TBL] [Abstract][Full Text] [Related]
7. B7-H1 and CD8+ Treg: the enigmatic role of B7-H1 in peripheral tolerance.
Waisman A; Yogev N
Eur J Immunol; 2009 Jun; 39(6):1448-51. PubMed ID: 19499529
[TBL] [Abstract][Full Text] [Related]
8. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
[TBL] [Abstract][Full Text] [Related]
9. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
Blackburn SD; Crawford A; Shin H; Polley A; Freeman GJ; Wherry EJ
J Virol; 2010 Feb; 84(4):2078-89. PubMed ID: 19955307
[TBL] [Abstract][Full Text] [Related]
10. Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function.
Terawaki S; Tanaka Y; Nagakura T; Hayashi T; Shibayama S; Muroi K; Okazaki T; Mikami B; Garboczi DN; Honjo T; Minato N
Int Immunol; 2007 Jul; 19(7):881-90. PubMed ID: 17606978
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of antiviral immunity in HBV mouse model by blocking PD-1/PD-L1 signaling pathway].
Weng ZH; Ye P; Zhang SL
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):263-6. PubMed ID: 20460044
[TBL] [Abstract][Full Text] [Related]
12. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
14. Protect the killer: CTLs need defenses against the tumor.
Freeman GJ; Sharpe AH; Kuchroo VK
Nat Med; 2002 Aug; 8(8):787-9. PubMed ID: 12152031
[No Abstract] [Full Text] [Related]
15. Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockade.
Blackburn SD; Shin H; Freeman GJ; Wherry EJ
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15016-21. PubMed ID: 18809920
[TBL] [Abstract][Full Text] [Related]
16. Putting T cells to sleep: a new paradigm for immune evasion by persistent viruses.
Dubey S; Jameel S
J Biosci; 2006 Dec; 31(5):497-501. PubMed ID: 17301484
[No Abstract] [Full Text] [Related]
17. Interaction of programmed death-1 and programmed death-1 ligand-1 contributes to testicular immune privilege.
Cheng X; Dai H; Wan N; Moore Y; Vankayalapati R; Dai Z
Transplantation; 2009 Jun; 87(12):1778-86. PubMed ID: 19543053
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allografts.
Koga N; Suzuki J; Kosuge H; Haraguchi G; Onai Y; Futamatsu H; Maejima Y; Gotoh R; Saiki H; Tsushima F; Azuma M; Isobe M
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2057-62. PubMed ID: 15374847
[TBL] [Abstract][Full Text] [Related]
19. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
Martin-Orozco N; Wang YH; Yagita H; Dong C
J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
[TBL] [Abstract][Full Text] [Related]
20. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.
Haspot F; Fehr T; Gibbons C; Zhao G; Hogan T; Honjo T; Freeman GJ; Sykes M
Blood; 2008 Sep; 112(5):2149-55. PubMed ID: 18577709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
